OUR IMPACT

The Side-Out Foundation and Perthera, a market leader in Precision Oncology, and have forged a comprehensive partnership to deliver precision medicine and personalized treatment recommendations to physicians and patients throughout the country. Together, Perthera and Side-Out are launching a national clinical study program to improve outcomes for patients with advanced breast cancer, demonstrate the impact of precision oncology and accelerate clinical trial enrollment across the nation, to advance medicine & science through groundbreaking research publications.

Funded through Side-Out’s philanthropic support, all patients who have been molecularly profiled or who have upcoming testing can be enrolled in the program, regardless of geographical location or insurance status. Perthera’s highly trained clinical team will coordinate everything for each patient to ensure they can receive the testing required to advance their care and participate in the program. Patients, their oncologists and care teams, will be provided with significant resources, including Perthera’s precisely matched treatment recommendations proven to increase survival, clinical trial matching services shown to increase enrollment at 5X the national average, and Side-Out’s economic support to ensure patients receive these resources regardless of barriers. This program will capture highly comprehensive patient outcomes for utilization in research and publications to benefit breast cancer patients worldwide.